Text Size

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2006 by Asociación para Evitar la Ceguera en México.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Asociación para Evitar la Ceguera en México
ClinicalTrials.gov Identifier:
NCT00406172
First received: November 30, 2006
Last updated: December 4, 2006
Last verified: November 2006
History of Changes
  Purpose

To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.


Condition Intervention Phase
Cystoid Macular Edema
 Drug: Bevacizumab
 Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Resource links provided by NLM:

MedlinePlus related topics: Edema
Drug Information available for: Bevacizumab
U.S. FDA Resources

Further study details as provided by Asociación para Evitar la Ceguera en México:

  Eligibility

Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Pseudophakic eyes with macular edema

Exclusion Criteria:

  • Other retinopathies
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00406172

Contacts
Contact: Victoria Cubas-Lorenzo, MD (55) 10841400 ext 1171 retinamex@yahoo.com

Locations
Mexico
APEC Recruiting
México D.F., Mexico, 03040
Contact: Victoria Cubas-Lorenzo, MD     (55) 10841400 ext 1171     retinamex@yahoo.com    
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Investigators
Principal Investigator: Victoria Cubas-Lorenzo, MD APEC México
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00406172     History of Changes
Other Study ID Numbers: APEC 0016
Study First Received: November 30, 2006
Last Updated: December 4, 2006
Health Authority: México: Secretaría de Salubridad

Additional relevant MeSH terms:
Edema
Macular Edema
Signs and Symptoms
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases
Bevacizumab
 Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Growth Substances
Physiological Effects of Drugs
Pharmacologic Actions
Growth Inhibitors
Antineoplastic Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on June 13, 2013